Mark Woodruff

Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study

Antoîne Italiano, Jean‐Charles Soria, Maud Toulmonde et al. · The Lancet Oncology · 2018 · 597 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +8

Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults

Sam Jackson, Joseph R. Lentino, James Kopp et al. · Vaccine · 2017 · 185 citations · Full text

Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial

John H. Beigel, Yajing Bao, Joy Beeler et al. · The Lancet Infectious Diseases · 2017 · 94 citations · Full text

Antiviral Drug Development, Antiviral Therapy, Virology +5

Clinical characteristics of patients younger than 60 years with mitral anular calcium: Comparison with age- and sex-matched control subjects

Chandra K. Nair, Chris Sudhakaran, Wilbert S. Aronow et al. · The American Journal of Cardiology · 1984 · 69 citations

Ophthalmology, Medicine, Mitral Anular Calcium +3

Calcific valvular aortic stenosis with and without mitral anular calcium

Chandra K. Nair, Michael H. Sketch, Ismail Ahmed et al. · The American Journal of Cardiology · 1987 · 29 citations

Mitral Anular Calcium, Valve Disease, Valvular Heart Disease +4